Will Pharmacyte Biotech Inc (PMCB) Stay at the Bottom of the Healthcare Sector?

Pharmacyte Biotech Inc (PMCB) is around the bottom of the Healthcare sector according to InvestorsObserver. PMCB received an overall rating of 12, which means that it scores higher than 12% of stocks. Additionally, Pharmacyte Biotech Inc scored a 7 in the Healthcare sector, ranking it higher than 7% of stocks in that sector.

PMCB has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on PMCB!

See Full PMCB Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 12 would rank higher than 12 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Pharmacyte Biotech Inc Stock Today?

Pharmacyte Biotech Inc (PMCB) stock is down -1.41% while the S&P 500 has gained 0.12% as of 10:29 AM on Friday, Oct 27. PMCB is lower by -$0.03 from the previous closing price of $2.04 on volume of 1,644 shares. Over the past year the S&P 500 has gained 8.80% while PMCB is lower by -31.86%. PMCB lost -$0.54 per share the over the last 12 months. Click Here to get the full Stock Report for Pharmacyte Biotech Inc stock.